WW WW International (WW) Insider Trading, Ownership & Congress Trades
Services · Services-personal services · CIK 0000105319
Cluster · 5 insidersActivist 13DC-suite buying · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about WW
Insiders, 180 days
+$725.9K net bought
5 buyers
Activist stakes (13D), 180 days
1 filing
Largest: 8.4% of the class
WW International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, WW INTERNATIONAL, INC. insiders bought a net $725.9K of stock across 27 Form 4 purchases and sales, with 5 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 20, 2026.
- The trade is 36.9% of the 19,620 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Sjoqvist Nikolaj H bought about $100.1K of WW on Aug 18, 2026.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 26, 2026.
- +16.4% median (+16.4% mean) 90-day return after 2 previous buys.
- The trade is 41.4% of the 21,648 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director DAVIS EUGENE I bought about $132.6K of WW on May 27, 2026; 4 other insiders bought within 30 days.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 26, 2026.
- +16.4% median (+16.4% mean) 90-day return after 2 previous buys.
- The trade is 8.1% of the 12,677 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director DAVIS EUGENE I bought about $14.8K of WW on May 27, 2026; 4 other insiders bought within 30 days.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 22, 2026.
- The trade is 14.1% of the 11,648 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director DAVIS EUGENE I bought about $22.2K of WW on May 26, 2026; 4 other insiders bought within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 1,500 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: CFO & Member, IOCE DellaFortuna Felicia bought about $19.0K of WW on May 22, 2026; 4 other insiders bought within 30 days.27 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$725.9K over 180 days
+$100.1K over 90 days
more than 88% of Services
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-11.6% year over year
below 83% of Services
Margin
134.4% net margin
more than 99% of Services
Buybacks
no share repurchases reported
Short interest
25.9% of the float short (float per yahoo 2026-10-26) · 5.3 days to cover · settled 2026-09-30
more than 98% of Services
The situation: each line is one rule over one dataset
Galloway Capital Partners, LLC disclosed a 5%+ stake (8.42%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch WW
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-54.9%12M
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns WW: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in WW
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Galloway Capital Partners, LLC
Activist 13D · 2026-05-13
8.42%
Galloway Capital, LP
Activist 13D · 2026-05-13
8.42%
GALLOWAY BRUCE
Activist 13D · 2026-05-13
8.42%
WW planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Clinical pipeline
2 registered trials, 0 still running (ClinicalTrials.gov).
A status change is dated here weeks before the press release.
1
Phase 4
0 active
1
Not applicable
0 active
Matched by sponsor name. Trials run under a subsidiary's
own name are not included.
Executive pay vs shareholder return · Mssistani
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$8.9M
$12.5M
$1.4M
n/a
n/a
2021
$5.1M
-$234.5K
$1.9M
-57%
+38%
2020
$6.3M
-$6.1M
$1.8M
-35%
+20%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
5 insiders reported buying shares.
The record shows a net $725.9K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
WW financials
Revenue growth
-11.6%
XBRL, annual
Net margin
134.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$677.7M
four quarters, 2025-06-25 to 2026-06-30
Revenue, TTM WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | $785.9M |
| FY Dec 2023 | $889.6M |
| FY Dec 2022 | $1.0B |
| FY Jan 2022 | $1.2B |
| Jun 2026 | $162.3M |
| Mar 2026 | $168.3M |
| Dec 2025 | $162.8M |
| Sep 2025 | $184.3M |
| Jun 2025 | $177.0M |
| Mar 2025 | $186.6M |
| Dec 2024 | $184.4M |
| Sep 2024 | $192.9M |
At each fiscal year end
Single quarter
Net margin, TTM
-14.8%
net income over revenue, 2025-06-25 to 2026-06-30
Net margin, TTM WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | -44.0% |
| FY Dec 2023 | -12.6% |
| FY Dec 2022 | -24.7% |
| FY Jan 2022 | +5.5% |
| Jun 2026 | +8.7% |
| Mar 2026 | -30.9% |
| Dec 2025 | -3.6% |
| Sep 2025 | -30.5% |
| Jun 2025 | +672.7% |
| Mar 2025 | -38.9% |
| Dec 2024 | +13.6% |
| Sep 2024 | -23.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$4.0M
operating cash flow minus capex, 2025-06-25 to 2026-06-30
Free cash flow, TTM WW
| FY Dec 2025 | -$29.1M |
| FY Dec 2024 | -$17.6M |
| FY Dec 2023 | $4.2M |
| FY Dec 2022 | $74.6M |
| FY Jan 2022 | $154.8M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | $8.4M |
| Jun 2025 | -$49.5M |
| Mar 2025 | $15.0M |
| Dec 2024 | $4.5M |
| Sep 2024 | $16.7M |
At each fiscal year end
Single quarter
Debt to equity
1.62x
long-term 2026-06-30 plus current 2026-03-31; equity 2026-06-30
Debt to equity WW
| FY Dec 2025 | 6.50x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | 1.62x |
| Mar 2026 | 1.75x |
| Dec 2025 | 6.50x |
| Sep 2025 | 6.40x |
| Jun 2025 | 5.46x |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.01x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-03-31
Cash flow to debt WW
| FY Dec 2025 | -0.01x |
| FY Dec 2024 | -0.01x |
| FY Dec 2023 | 0.00x |
| FY Dec 2022 | 0.05x |
| FY Jan 2022 | 0.11x |
| Jun 2026 | -0.01x |
| Mar 2026 | -0.17x |
| Dec 2025 | -0.01x |
| Sep 2025 | -0.01x |
| Jun 2025 | -0.01x |
| Mar 2025 | 0.01x |
| Dec 2024 | -0.01x |
| Sep 2024 | -0.01x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-30.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | -30.3% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-10.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | -45.1% |
| FY Dec 2023 | -11.2% |
| FY Dec 2022 | -20.9% |
| FY Jan 2022 | +4.6% |
| Jun 2026 | -10.7% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | +134.0% |
| Mar 2025 | -10.4% |
| Dec 2024 | -45.1% |
| Sep 2024 | -57.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | +22.3% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-2.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | -41.0% |
| FY Dec 2023 | +2.8% |
| FY Dec 2022 | -28.0% |
| FY Jan 2022 | +16.8% |
| Jun 2026 | -2.9% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | +2.8% |
| Mar 2025 | n/a |
| Dec 2024 | -41.0% |
| Sep 2024 | -46.0% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$486.3M
market value at close 2026-10-27 on 2026-07-30 shares, plus long-term 2026-06-30 plus current 2026-03-31, minus cash 2026-06-30
Enterprise value WW
| FY Dec 2025 | $2.2B |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | $509.1M |
| Mar 2026 | $481.9M |
| Dec 2025 | $2.2B |
| Sep 2025 | $2.2B |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-2.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield WW
| FY Dec 2025 | -10.0% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | -2.5% |
| Mar 2026 | -56.5% |
| Dec 2025 | -10.0% |
| Sep 2025 | -7.9% |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing WW
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Jan 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2025-06 | 2024-12 | 2023-12 | |
|---|---|---|---|---|
| Revenue | n/a | n/a | $785.9M | $889.6M |
| Gross profit | n/a | n/a | $533.1M | $529.3M |
| Operating income | n/a | n/a | -$236.2M | $22.3M |
| Net income | $1.1B | n/a | -$345.7M | -$112.3M |
| EPS (diluted) | n/a | n/a | -4.34 | -1.46 |
| Operating cash flow | n/a | n/a | -$16.8M | $6.7M |
| Cash | $160.3M | $140.6M | $53.0M | $109.4M |
| Long-term debt | $465.5M | $465.5M | $1.4B | $1.4B |
SEC XBRL, fiscal years, as known on 2026-10-28
WW Stock Sonar score 6/7 axes
Find similar shapesCompareWW ranks highest on insider conviction (92nd percentile) and profitability (27th), and lowest on risk and compliance (10th), among Services peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
WW filings, in plain words
Are WW International insiders buying or selling WW?
In the 180 days to 2026-10-28, WW International insiders were net buyers, a net $725.9K across purchases and sales reported on Form 4, by 5 buyers.
Read the full summary
In the 180 days to 2026-10-28, WW International insiders were net buyers of WW, a net $725.9K across purchases and sales reported on Form 4 by 5 buyers. 5 insiders reported purchases in that window. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 8.4% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
